Raghiatou Baldé on Muck Rack

Raghiatou Baldé

As seen in: The BMJ, HAL
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Raghiatou

Contact Raghiatou, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Safety and tolerability of immune checkpoint inhibitors in people with HIV infection and cancer: insights from the national prospective real-world OncoVIHAC ANRS CO24 cohort study

|
By Lambert Assoumou, de Santé Publique, Raghiatou Baldé, Christine Katlama
| HAL
Article Dans Une Revue Journal for Immunotherapy of Cancer Année : 2024 Safety and tolerability of immune checkpoint inhibitors in people with HIV infection and cancer: insights from the national prospective real-world OncoVIHAC ANRS CO24 cohort study hal-05038334 , version 1 (17-04-2025) Lambert Assoumou, Raghiatou Baldé, Christine Katlama, Baptiste Abbar, Pierre Delobel, et al..
Open in Who Shared Issue with article?

Safety and tolerability of immune checkpoint inhibitors in people with HIV infection and cancer: insights from the national prospective real-world OncoVIHAC ANRS CO24 cohort study

|
By Lambert Assoumou, Christine Katlama, Baptiste Abbar, Raghiatou Baldé
| The BMJ Verified
Discussion As HIV can be considered a chronic disease when HIV viral replication is durably suppressed, prolonged life together with persistent damages in the immune system, high prevalence of persistent oncogenic viruses and increased exposure hazards have moved cancer as a leading cause of death in PWH and a new challenge for clinical management of both entities, cancer and HIV.
Open in Who Shared Issue with article?
See all 2 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified